Home › Colon Cancer › Pennsylvania › Harrisburg
Colon Cancer clinical trials in Harrisburg, PA
3 studies for Colon Cancer are looking for participants at sites in and around Harrisburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecruitingPhase 3
- Penn State Milton S. Hershey Medical Center, Hershey · 12 mi away
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecruitingPhase 2/3
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi away
- Penn State Milton S Hershey Medical Center, Hershey · 12 mi away
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RecruitingPhase 2
- Penn State Milton S. Hershey Medical Center, Hershey · 12 mi away
Colon Cancer trials in other cities
- Boston, MA22 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Los Angeles, CA16 studies
- Nashville, TN16 studies
- St. Louis, MO15 studies
- Arlington, VA15 studies
- Chicago, IL14 studies
- San Antonio, TX14 studies
- Baldwin Park, CA14 studies
- Baltimore, MD13 studies
- Tampa, FL13 studies
Other studies in Harrisburg
- Heart Failure14 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer12 studies
- Cardiovascular Disease11 studies
- Lung Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Colorectal Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Neuroblastoma6 studies
- Crohn's Disease6 studies
- High Blood Pressure6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.